USD 0.02
(14.44%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | -492 Thousand USD | -134.29% |
2022 | -210 Thousand USD | -17.98% |
2021 | -178 Thousand USD | -302.27% |
2020 | 88 Thousand USD | -95.75% |
2019 | 2.07 Million USD | 81.88% |
2018 | 1.13 Million USD | 72.69% |
2017 | 660 Thousand USD | -73.97% |
2016 | 2.53 Million USD | -17.15% |
2015 | 3.06 Million USD | -46.62% |
2014 | 5.73 Million USD | -27.93% |
2013 | 7.95 Million USD | 111.93% |
2012 | 3.75 Million USD | -24.92% |
2011 | 5 Million USD | 15013.5% |
2010 | 33.08 Thousand USD | -99.12% |
2009 | 3.76 Million USD | -30.56% |
2008 | 5.41 Million USD | -43.94% |
2007 | 9.66 Million USD | -29.51% |
2006 | 13.7 Million USD | -17.02% |
2005 | 16.52 Million USD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q1 | -110 Thousand USD | -117.89% |
2024 Q2 | -96 Thousand USD | 12.73% |
2023 Q3 | -128 Thousand USD | -7.56% |
2023 Q1 | -122 Thousand USD | -114.04% |
2023 Q2 | -119 Thousand USD | 2.46% |
2023 FY | -492 Thousand USD | -134.29% |
2023 Q4 | 615 Thousand USD | 580.47% |
2022 Q2 | -54 Thousand USD | 0.0% |
2022 FY | -210 Thousand USD | -17.98% |
2022 Q1 | -54 Thousand USD | 8.47% |
2022 Q4 | -57 Thousand USD | -26.67% |
2022 Q3 | -45 Thousand USD | 16.67% |
2021 Q2 | -51 Thousand USD | -218.75% |
2021 Q1 | -16 Thousand USD | 0.0% |
2021 Q4 | -59 Thousand USD | -13.46% |
2021 Q3 | -52 Thousand USD | -1.96% |
2021 FY | -178 Thousand USD | -302.27% |
2020 Q4 | - USD | 0.0% |
2020 Q1 | 120 Thousand USD | -94.21% |
2020 FY | 88 Thousand USD | -95.75% |
2020 Q2 | - USD | -100.0% |
2020 Q3 | - USD | 0.0% |
2019 Q2 | - USD | 0.0% |
2019 Q3 | - USD | 0.0% |
2019 Q4 | 2.07 Million USD | 0.0% |
2019 FY | 2.07 Million USD | 81.88% |
2019 Q1 | - USD | 0.0% |
2018 Q3 | - USD | 0.0% |
2018 FY | 1.13 Million USD | 72.69% |
2018 Q2 | - USD | -100.0% |
2018 Q1 | 237 Thousand USD | 0.0% |
2018 Q4 | - USD | 0.0% |
2017 Q4 | - USD | 0.0% |
2017 Q3 | - USD | 0.0% |
2017 FY | 660 Thousand USD | -73.97% |
2017 Q2 | - USD | -100.0% |
2017 Q1 | 669 Thousand USD | -1.04% |
2016 Q4 | 676 Thousand USD | 10.82% |
2016 Q3 | 610 Thousand USD | 0.0% |
2016 FY | 2.53 Million USD | -17.15% |
2016 Q2 | 610 Thousand USD | -4.69% |
2016 Q1 | 640 Thousand USD | -4.48% |
2015 FY | 3.06 Million USD | -46.62% |
2015 Q3 | 683 Thousand USD | -20.02% |
2015 Q4 | 670 Thousand USD | -1.9% |
2015 Q2 | 854 Thousand USD | 0.0% |
2015 Q1 | 854 Thousand USD | -4.69% |
2014 Q2 | 1.98 Million USD | -0.3% |
2014 FY | 5.73 Million USD | -27.93% |
2014 Q1 | 1.99 Million USD | 0.3% |
2014 Q4 | 896 Thousand USD | 4.92% |
2014 Q3 | 854 Thousand USD | -57.06% |
2013 Q4 | 1.98 Million USD | 0.0% |
2013 Q3 | 1.98 Million USD | 0.0% |
2013 FY | 7.95 Million USD | 111.93% |
2013 Q2 | 1.98 Million USD | 0.0% |
2013 Q1 | 1.98 Million USD | 0.0% |
2012 Q3 | 265 Thousand USD | -82.33% |
2012 FY | 3.75 Million USD | -24.92% |
2012 Q4 | 1.98 Million USD | 650.57% |
2012 Q1 | - USD | 0.0% |
2012 Q2 | 1.5 Million USD | 0.0% |
2011 Q3 | 1 Million USD | 0.0% |
2011 Q1 | 4 Million USD | 66566.67% |
2011 Q2 | - USD | -100.0% |
2011 FY | 5 Million USD | 15013.5% |
2011 Q4 | - USD | -100.0% |
2010 Q2 | 14.58 Thousand USD | 16.66% |
2010 FY | 33.08 Thousand USD | -99.12% |
2010 Q4 | 6000.00 USD | 0.0% |
2010 Q3 | - USD | -100.0% |
2010 Q1 | 12.5 Thousand USD | 0.0% |
2009 FY | 3.76 Million USD | -30.56% |
2009 Q3 | 12.5 Thousand USD | -99.64% |
2009 Q2 | 3.51 Million USD | 1467.75% |
2009 Q1 | 224.04 Thousand USD | 1692.38% |
2009 Q4 | 12.5 Thousand USD | 0.0% |
2008 Q1 | 2.3 Million USD | 12.53% |
2008 Q3 | 510.41 Thousand USD | -80.3% |
2008 Q4 | 12.5 Thousand USD | -97.55% |
2008 Q2 | 2.59 Million USD | 12.51% |
2008 FY | 5.41 Million USD | -43.94% |
2007 Q3 | 1.83 Million USD | -44.03% |
2007 Q2 | 3.27 Million USD | 29.96% |
2007 Q1 | 2.51 Million USD | 28.71% |
2007 Q4 | 2.04 Million USD | 11.83% |
2007 FY | 9.66 Million USD | -29.51% |
2006 Q2 | 6.7 Million USD | 116.55% |
2006 Q4 | 1.95 Million USD | 0.3% |
2006 FY | 13.7 Million USD | -17.02% |
2006 Q1 | 3.09 Million USD | -31.51% |
2006 Q3 | 1.94 Million USD | -70.94% |
2005 Q3 | 3.34 Billion USD | 0.0% |
2005 FY | 16.52 Million USD | 0.0% |
2005 Q4 | 4.52 Million USD | -99.86% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
America Great Health | 168.58 Thousand USD | 391.836% |
Ampio Pharmaceuticals, Inc. | -250 Thousand USD | -96.8% |
Aridis Pharmaceuticals, Inc. | - USD | Infinity% |
Biora Therapeutics, Inc. | -551 Thousand USD | 10.708% |
Bio-Path Holdings, Inc. | -178 Thousand USD | -176.404% |
Better Therapeutics, Inc. | -2.72 Million USD | 81.971% |
Calithera Biosciences, Inc. | -1.38 Million USD | 64.477% |
Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | 216.391% |
Gene Biotherapeutics, Inc. | - USD | Infinity% |
eFFECTOR Therapeutics, Inc. | -22.91 Million USD | 97.853% |
Eloxx Pharmaceuticals, Inc. | - USD | Infinity% |
Evelo Biosciences, Inc. | - USD | Infinity% |
Evolutionary Genomics, Inc. | -1.02 Million USD | 51.835% |
Finch Therapeutics Group, Inc. | -7.09 Million USD | 93.063% |
Galera Therapeutics, Inc. | -259 Thousand USD | -89.961% |
Innovation1 Biotech Inc. | -52.69 Thousand USD | -833.622% |
Kiromic BioPharma, Inc. | -2.79 Million USD | 82.403% |
Molecular Templates, Inc. | 50.39 Million USD | 100.976% |
Navidea Biopharmaceuticals, Inc. | -119.29 Thousand USD | -312.423% |
NexImmune, Inc. | -1.02 Million USD | 51.999% |
Orgenesis Inc. | -5.72 Million USD | 91.406% |
Panbela Therapeutics, Inc. | -25.64 Million USD | 98.082% |
Point of Care Nano-Technology, Inc. | -4601.00 USD | -10593.328% |
PaxMedica, Inc. Common Stock | - USD | Infinity% |
Scopus BioPharma Inc. | - USD | Infinity% |
Sorrento Therapeutics, Inc. | 29.38 Million USD | 101.674% |
Statera Biopharma, Inc. | -488.31 Thousand USD | -0.755% |
TRACON Pharmaceuticals, Inc. | -232 Thousand USD | -112.069% |
Trevena, Inc. | 1.45 Million USD | 133.814% |
Vaxxinity, Inc. | -2.23 Million USD | 77.977% |
Vaccinex, Inc. | -16 Million USD | 96.926% |
Vicapsys Life Sciences, Inc. | - USD | Infinity% |
ZIVO Bioscience, Inc. | 11.61 Thousand USD | 4337.726% |